Page 60 - 南京医科大学学报自然科学版

第42卷第4期
·510 · 南 京 医 科 大 学 学 报 2022年4月

1223 patients sensitive and resistant to imatinib treatment show
［2］ FLOETH M，ELGES S，GERSS J，et al. Low⁃density lipo⁃ different metabolic responses［J］. PLoS One，2010，5
protein receptor（LDLR）is an independent adverse prog⁃ （10）：e13186
nostic factor in acute myeloid leukaemia［J］. Br J Haema⁃ ［14］ ZHANG X X，WEI M，SHANG L X，et al. LDL⁃C/HDL⁃C
tol，2021，192（3）：494-503 is associated with ischaemic stroke in patients with non⁃
［3］ GOTLIB J. World Health Organization⁃defined eosinophil⁃ valvular atrial fibrillation：a case⁃control study［J］. Lipids
ic disorders：2015 update on diagnosis，risk stratification， Health Dis，2020，19（1）：217
and management［J］. Am J Hematol，2015，90（11）： ［15］ CHEN Z，HU H，CHEN M，et al. Association of triglycer⁃
1077-1089 ide to high⁃density lipoprotein cholesterol ratio and inci⁃
［4］ BACCARANI M，DEININGER M W，ROSTI G，et al. Eu⁃ dent of diabetes mellitus：a secondary retrospective analy⁃
ropean leukemia net recommendations for the manage⁃ sis based on a Chinese cohort study［J］. Lipids Health
ment of chronic myeloid leukemia：2013［J］. Blood，2013， Dis，2020，9（1）：33
122（6）：872-884 ［16］ TIAN M，LI R，SHAN Z，et al. Comparison of Apolipopro⁃
［5］ LI Y，CHEN X，LI S，et al. Non⁃high⁃density lipoprotein tein B/A1 ratio，Framingham risk score and TC/HDL⁃c for
cholesterol/high ⁃ density lipoprotein cholesterol ratio predicting clinical outcomes in patients undergoing percu⁃
serve as a predictor for coronary collateral circulation in taneous coronary intervention［J］. Lipids Health Dis，
chronic total occlusive patients［J］. BMC Cardiovasc Dis⁃ 2019，18（1）：202
ord，2021，21（1）：311 ［17］ PENG J，ZHAO F，YANG X，et al. Association between
［6］ WU Z，HUANG Z，LICHTENSTEIN A H，et al. The risk dyslipidemia and risk of type 2 diabetes mellitus in mid⁃
of ischemic stroke and hemorrhagic stroke in Chinese dle⁃aged and older Chinese adults：a secondary analysis
adults with low⁃density lipoprotein cholesterol concentra⁃ of a nationwide cohort［J］. BMJ Open，2021，11（5）：
tions < 70 mg/dL［J］. BMC Med，2021，19（1）：142 e042821
［7］ PATEL K K，KASHFI K. Lipoproteins and cancer：the ［18］ ZOU Y，ZHONG L，HU C，et al. LDL/HDL cholesterol ra⁃
role of HDL⁃C，LDL⁃C，and cholesterol⁃lowering drugs tio is associated with new⁃onset NAFLD in Chinese non⁃
［J］. Biochem Pharmacol，2022，196：114654 obese people with normal lipids：a 5⁃year longitudinal co⁃
［8］ JEONG S M，CHOI T，KIM D，et al. Association between hort study［J］. Lipids Health Dis，2021，20（1）：28
high⁃density lipoprotein cholesterol level and risk of he⁃ ［19］ MAHTO M，CHAKRABORTHY B，GOWDA S H，et al.
matologic malignancy［J］. Leukemia，2021，35（5）：1356- Are hsCRP levels and LDL/HDL ratio better and early
1364 markers to unmask onset of dyslipidemia and inflamma⁃
［9］ ZHOU B，REN H，ZHOU X，et al. Associations of iron sta⁃ tion in asymptomatic subclinical hypothyroidism?［J］. In⁃
dian J Clin Biochem，2012，27（3）：284-289
tus with apolipoproteins and lipid ratios：a cross⁃sectional
study from the China health and nutrition survey［J］. Lip⁃ ［20］ KUCUK A，UGUR USLU A，ICLI A，et al. The LDL/HDL
ids Health Dis，2020，19（1）：140 ratio and atherosclerosis in ankylosing spondylitis［J］. Z
［10］ BONOMO LDE F，SILVA M，OLIVEIRA RDE P，et al. Rheumatol，2017，76（1）：58-63
Iron overload potentiates diet ⁃ induced hypercholesterol⁃ ［21］ NEGRE⁃SALVAYRE A，DOUSSET N，FERRETTI G，et
al. Antioxidant and cytoprotective properties of high⁃den⁃
emia and reduces liver PPAR⁃ α expression in hamsters
［J］. J Biochem Mol Toxicol，2012，26（6）：224-229 sity lipoproteins in vascular cells［J］. Free Radic Biol
Med，2006，41（7）：1031-1040
［11］ SILVA M，DA COSTA GUERRA J F，SAMPAIO A F，et
［22］ YVAN⁃CHARVET L，PAGLER T，GAUTIER E L，et al.
al. Iron dextran increases hepatic oxidative stress and al⁃
ATP⁃binding cassette transporters and HDL suppress he⁃
ters expression of genes related to lipid metabolism con⁃
matopoietic stem cell proliferation［J］. Science，2010，328
tributing to hyperlipidaemia in murine model［J］. Biomed
（5986）：1689-1693
Res Int，2015，2015：272617
［23］ GALLAGHER E J，ZELENKO Z，NEEL B A，et al. Ele⁃
［12］ POUWER M G，PIETERMAN E J，VERSCHUREN L，et
vated tumor LDLR expression accelerates LDL cholesterol
al. The BCR⁃ABL1 inhibitors imatinib and ponatinib de⁃
⁃mediated breast cancer growth in mouse models of hyper⁃
crease plasma cholesterol and atherosclerosis，and nilo⁃
lipidemia［J］. Oncogene，2017，36（46）：6462-6471
tinib and ponatinib activate coagulation in a translational
［24］ GUO D，REINITZ F，YOUSSEF M，et al. An LXR agonist
mouse model［J］. Front Cardiovasc Med，2018，5：55
［13］ A J，QIAN S，WANG G，et al. Chronic myeloid leukemia （下转第521页）